Commencez à traiter la myopie dès aujourd'hui !

Optometrist and parent, Dr. Hannah Yecheskel calls MiSight® 1 day the “answer” to her 8-year old daughter’s rapidly progressing myopia.

Watch Video

Important Product Safety Information

Apprenez davantage sur MiSight® 1 day pour la gestion de la copie

Écoutez le vidéo de 15 minutes QuickStart™ pour commencer dès aujourd'hui.

Démarrer avec MiSight® 1 day n'a jamais été aussi facile ! Le programme MiSight® QuickStart™ offre des outils pour aider les pratiques à commencer à prescrire dès aujourd'hui avec des séances guidées en personne ou à la demande, des conseils et des techniques de conversation avec les parents de la part de médecins pairs, des ressources de formation du personnel et plus encore.

Log in to the CooperVision MiSight Pro Center, ou inscrivez-vous aujourd'hui pour explorer tout ce que MiSight® QuickStart™ peut vous offrir.

Commencez dès aujourd'hui !

Dual-benefit of
MiSight® 1 day:

CORRECTS BLURRY DISTANCE VISION

Children wearing MiSight® 1 day achieved better than 20/20 vision across all visits over a 6-year period.^*1,2

+

HELPS TREAT MYOPIA TO SLOW ITS PROGRESSION

On average, age-appropriate children wearing MiSight® 1 day progressed less than -1.00D over 6 years.^‡3

MiSight® 1 day myopia control soft contact lenses are the first FDA-approved product proven to slow myopia progression in children, aged 8-12 at the initiation of treatment

APPROVÊE PAR LA FDA*

Les lentilles cornéennes MiSightMD 1 day sont les premières et les seules lentilles cornéennes souples approuvées par la FDA* pour ralentir la progression de la myopie chez les enfants âgés de 8 à 12 ans au début du traitement.^†1

En savoir plus

HOW MISIGHT® 1 DAY WORKS

COMMENT MISIGHT® 1 DAY FONCTIONNE

Take a look at how ActivControl® Technology helps reduce the rate of myopia progression in children by 59% on average.^†1

Écoutez le vidéo

SUPPORTED BY A 7-YEAR STUDY

SUPPORTÉE PAR UNE ÉTUDE DE 7 ANS

Evidence-based medicine: See the results of the 7-year international study demonstrating a strong safety profile.^*†1-4

Learn More

La gestion de la myopie est une norme de soins

We can no longer let myopia get worse. Treat this disease seriously – your professional associations have spoken.⁵

DECEMBER 2020

APRIL 2021

JUNE 2021

L'Histoire de Vera

Overcoming her family history of high myopia with MiSight® 1 day.

Écoutez maintenant

MiSight® 1 day Resources

White Paper

Treating Myopia as a Disease recently published on Healio

ECP Viewpoints^SM

Professional development blog and Online Success Center

Resources for Patients

MiSight.com, MiSight® on Facebook and Instagram

MiSight® on YouTube

Programming for Eye Care Professionals, patients and parents

Make Children's SightYour Fight^™.

*Indications and Important Safety Information.
Rx only.
Results may vary.

ATTENTION: Reference the Patient Information Booklet for a complete listing of Indications and Important Safety Information.

*Only FDA approved soft contact lens designed for myopia control in the U.S.
†USA Indications for use: MiSight® 1 day (omafilcon A) soft (hydrophilic) contact lenses for daily wear are indicated for the correction of myopic ametropia and for slowing the progression of myopia in children with non-diseased eyes, who at the initiation of treatment are 8-12 years of age and have a refraction of -0.75 to -4.00 diopters(spherical equivalent) with ≤ 0.75 diopters of astigmatism. The lens is to be discarded after each removal. Canadian Indications for Use: MiSight (omafilcon A) Soft Contact Lenses for Myopia Control may reduce the rate of myopia progression in children (6-18) and correct ametropia. Reduction of myopia progression was observed in children with wearing time of 12 hours (8-16 hours) per day, 6.4 days (5-7) per week in a clinical study. Permanent myopia control after lens treatment is discontinued is not supported by clinical studies. MiSight (omafilcon A) Soft Contact Lenses for Myopia Control are indicated for single use daily disposable wear. When prescribed for daily disposable wear, the lens is to be discarded after each removal.

† Compared to a single vision 1 day lens over a 3-year period.

‡ Fitted at 8-12 years of age at initiation of treatment.

References:
1. Chamberlain P, et al. A 3-year Randomized Clinical Trial of MiSight® Lenses for Myopia Control. Optom Vis Sci. 2019; 96(8)556-567.
2. Chamberlain P, Arumugam B, Jones D et al. Myopia Progression in Children wearing Dual-Focus Contact Lenses: 6- year findings. Optom Vis Sci 2020;97(Eabstract): 200038.
3. Chamberlain P, Arumugam B, et al. Myopia progression on cessation of Dual-Focus contact lens wear: MiSight 1 day 7-year findings. Optom Vis Sci 2021;98 (Eabstract): 210049.
4. Woods, J., Jones, D., Jones, L., Jones, S., Hunt, C., Chamberlain, P., & McNally, J. (2021). Ocular health of children wearing daily disposable contact lenses over a 6-year period. Contact Lens and Anterior Eye.
5. Resolution: The standard of care for Myopia Management by Optometrists. World Council of Optometry. (2021, May 17). https://worldcouncilofoptometry.info/resolution-the-standard-of-care-for-myopiamanagement-byoptometrists.

MiSight® 1 day is a registered trademark of The Cooper Companies, Inc. and its subsidiaries.

Vous êtes ici

Prescrire MiSight® 1 day est facile | Professionnels de la vue CooperVision